|
![2-哌嗪-1-基-喹噁啉结构式]()
2-哌嗪-1-基-喹噁啉
55686-91-4
|
|
文献：NEUROGEN CORPORATION; SCHERING CORPORATION Patent: EP1025097 B1, 2005 ; Location in patent: Page/Page column 13 ;
|
|
![2-哌嗪-1-基-喹噁啉结构式]()
2-哌嗪-1-基-喹噁啉
55686-91-4
|
|
文献：Lumma Jr.; Hartman; Saari; Engelhardt; Lotti; Stone Journal of Medicinal Chemistry, 1981 , vol. 24, # 1 p. 93 - 101
|
![2-哌嗪-1-基-喹噁啉结构式]()
2-哌嗪-1-基-喹噁啉
55686-91-4
|
|
文献：Duncton, Matthew A. J.; Roffey, Jonathan R. A.; Hamlyn, Richard J.; Adams, David R. Tetrahedron Letters, 2006 , vol. 47, # 15 p. 2549 - 2552
|
![2-哌嗪-1-基-喹噁啉结构式]()
2-哌嗪-1-基-喹噁啉
55686-91-4
|
|
文献：Chandra Sekhar, Kondapalli Venkata Gowri; Rao, Vajja Sambasiva; Deuther-Conrad, Winnie; Sridhar, Divya; Nagesh, Hunsur Nagendra; Kumar, Vellas Sreedhar; Brust, Peter; Kumar, Muthyala Murali Krishna Medicinal Chemistry Research, 2013 , vol. 22, # 4 p. 1660 - 1673
|
![2-哌嗪-1-基-喹噁啉结构式]()
2-哌嗪-1-基-喹噁啉
55686-91-4
|
|
文献：Chandra Sekhar, Kondapalli Venkata Gowri; Rao, Vajja Sambasiva; Deuther-Conrad, Winnie; Sridhar, Divya; Nagesh, Hunsur Nagendra; Kumar, Vellas Sreedhar; Brust, Peter; Kumar, Muthyala Murali Krishna Medicinal Chemistry Research, 2013 , vol. 22, # 4 p. 1660 - 1673
|
CAS号55686-71-0